Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

SHE:300584 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 19, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,966	2,419	2,794	3,864	2,400	2,462
Market Cap Growth	105.05%	-13.40%	-27.70%	61.00%	-2.53%	-27.13%
Enterprise Value	5,217	2,671	2,943	3,897	2,479	2,522
Last Close Price	41.38	20.10	23.14	32.00	19.73	20.11
PE Ratio	110.91	60.15	76.93	119.08	8.40	44.58
Forward PE	-	26.20	26.20	26.20	26.20	26.20
PS Ratio	8.07	4.80	5.40	7.34	4.15	3.49
PB Ratio	4.63	2.33	2.83	4.07	2.53	3.63
P/TBV Ratio	5.40	2.74	3.25	4.73	2.90	4.19
P/OCF Ratio	66.65	40.35	116.73	-	40.04	33.55
EV/Sales Ratio	8.48	5.30	5.68	7.40	4.29	3.57
EV/EBITDA Ratio	46.08	25.38	29.58	47.13	37.32	25.96
EV/EBIT Ratio	85.68	50.98	64.05	112.54	84.27	38.45
Debt / Equity Ratio	0.28	0.30	0.27	0.19	0.19	0.25
Debt / EBITDA Ratio	2.63	2.99	2.72	2.15	2.71	1.75
Net Debt / Equity Ratio	0.21	0.26	0.23	0.09	0.07	0.08
Net Debt / EBITDA Ratio	1.95	2.56	2.25	1.00	0.97	0.59
Net Debt / FCF Ratio	-225.83	-14.96	-1.29	-0.37	-1.88	-1.22
Asset Turnover	0.42	0.35	0.38	0.41	0.52	0.80
Inventory Turnover	1.36	1.11	1.39	2.24	1.74	2.40
Quick Ratio	0.75	0.74	0.64	0.96	0.79	1.22
Current Ratio	1.01	1.07	0.94	1.19	1.00	1.62
Return on Equity (ROE)	4.25%	3.96%	3.75%	3.38%	35.00%	8.18%
Return on Assets (ROA)	2.62%	2.28%	2.13%	1.67%	1.67%	4.62%
Return on Invested Capital (ROIC)	4.56%	4.07%	3.94%	3.38%	2.90%	8.55%
Return on Capital Employed (ROCE)	5.40%	4.60%	4.60%	3.50%	2.90%	9.00%
Earnings Yield	0.90%	1.66%	1.30%	0.84%	11.91%	2.24%
FCF Yield	-0.02%	-0.74%	-6.20%	-5.82%	-1.44%	-1.90%
Dividend Yield	0.24%	0.50%	0.22%	-	1.27%	0.62%
Payout Ratio	44.02%	34.44%	17.80%	109.40%	7.70%	66.97%
Buyback Yield / Dilution	0.01%	-0.01%	-0.01%	-0.00%	-0.01%	0.01%
Total Shareholder Return	0.24%	0.49%	0.21%	-0.00%	1.26%	0.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.